View in EDS

Immunomodulation of Pancreatic Cancer via Inhibition of SUMOylation and the CD155/TIGIT Pathway.

Saved in:

Bibliographic Details
Title:	Immunomodulation of Pancreatic Cancer via Inhibition of SUMOylation and the CD155/TIGIT Pathway.
Authors:	De la Torre Medina J; Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California., Joshi U; Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California., Sonowal H; Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California., Kuang Y; Division of Surgical Sciences, Department of Surgery, UC San Diego, San Diego, California., Ren T; Division of Surgical Sciences, Department of Surgery, UC San Diego, San Diego, California., Chen DH; Division of Surgical Sciences, Department of Surgery, UC San Diego, San Diego, California., Tharuka MDN; Division of Surgical Sciences, Department of Surgery, UC San Diego, San Diego, California., Nguyen-Ta K; Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California., Gros HL; Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California., Mikulski Z; La Jolla Institute of Immunology, San Diego, California., Chen Y; Division of Surgical Sciences, Department of Surgery, UC San Diego, San Diego, California., White RR; Division of Surgical Oncology, Departmen of Surgery, UC San Diego, San Diego, California.
Source:	Molecular cancer therapeutics [Mol Cancer Ther] 2026 Jun 01; Vol. 25 (6), pp. 957-966.
Publication Type:	Journal Article
Journal Info:	Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1538-8514
DOI:	10.1158/1535-7163.MCT-25-0129